Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


December 9-13, 2018
Manchester Grand Hyatt San Diego,
San Diego, CA

Accelerate Your Next Generation Antibodies Towards Commercial Success

Attend the #1 forum for scientific exchange and networking in the fields of antibody engineering and therapeutics, immunobiology and next-generation binders

Don't Wait!

Register by August 17th and Save Up to $400


The Most Innovative Science Presented by Leading Industry and Academic Experts

Expand your pipeline of antibody therapeutics by hearing 125+ case studies, new data and industry updates from experts working across the entire spectrum of antibody development and production.

The Largest Exhibition Devoted to Antibody Engineering

Accelerate your promising therapeutic towards commercial success by connecting with 75+ leading technology and service providers.

The Leading Forum to Partner with Global Antibody Innovators and Suppliers

Fast-track your antibody research to the clinic and beyond by collaborating with 900+ attendees from leading pharma, biotechs, academia and solution providers from North America, Asia and Europe

New and Refreshed for 2018!

  • Discover strategies to help accelerate your antibody drug to the clinic by hearing NEW DATA from 125+ speakers who will share results from their preclinical and clinical drug development programs.
  • Find new applications and gain a competitive advantage for your antibody therapeutic by learning about NEW TARGETS and non-cancer therapeutic Indications through multiple case studies to be presented
  • Learn how to exploit the immune system for therapeutic potential by attending a NEW PRE-CONFERENCE WORKSHOP on “Immuno-engineering: Bridging the Immune System and Antibody Therapeutics”
  • Expand your target universe for antibody therapeutics by attending a NEW SESSION this year on “Novel Methods to Interrogate Receptors as Targets”
  • Discover NEW “RISK MITIGATION" STRATEGIES for immunogenicity and learn how to predict immunogenicity in your antibody drugs to help you avoid costly delays in your therapeutic pipeline
  • Learn about NEW FRONTIERS in therapeutic development including a new session this year on the “Microbiome”


Leading Academic and Industry Scientists
Global Speaker Presentations
Scientific Poster Presentations
Technology and Solution Providers
Hours to Network

Submit a Poster at Antibody Engineering & Therapeutics

Share your company's new research by presenting a poster at Antibody Engineering & Therapeutics.

Please note that all poster presenters must be registered attendees.  

The deadline to submit an abstract and be included in the conference documentation is Friday, November 9, 2018 (full payment for conference and poster fee must be received by this date). After that date, posters are on a space-available basis.

Submitting an abstract does not guarantee acceptance of your poster. You will be notified by the Event Review Committee if your presentation has been selected.


Taylor Gray, Adimab,LLC

“This was a great conference for people of all experience levels in this field. The talks covered a wide range of topics and gave me a great overview of current happenings in antibody engineering. I am coming away from this conference with a good understanding of where this field currently is and where it is going."

Claire Nauman, Adimab, LLC

"A well-organized conference packed with informative and interesting talks, presented in an accessible format that facilitates networking and communication."

Liz Wilson, Agensys

"A great program that was very dense and informative on the emerging topics in the field of antibody therapeutics."

Rossana Nadell, Agensys

"This was an interesting conference bringing people together from UK, Germany and USA. The topics were mostly antibody/antigen-related and up to date."

Jian Yao, TopAlliance Biosciences

"Great conference, topics are well-chosen and cover a broad spectrum of interests. Plenty of opportunities to interact with other attendees. This is the conference to go to if you need to keep up with the fast-paced therapeutic antibody industry."

Marco Thomann, Roche Diagnostics, Germany

"Great conference, well-balanced between industry and academic, with interesting topics and really good speakers!"

Mark Cobbold, University of Birmingham

"One of the best conferences I have attended. A fantastic venue, program and conference designed to optimize networking and keep you up-to-date in the field."

About the Antibody Society

The Antibody Society is an international, non-profit association representing individuals and organizations involved in antibody-related research and development. Our members serve as the Scientific Advisors for the Antibody Engineering & Therapeutics (US) and the Antibody Engineering & Therapeutics Europe conferences. To provide additional opportunities for education and networking, we contribute scientific content and financial support for other conferences that cover topics relevant to antibody R&D, and are hosted by non-profit organizations. We research and analyze data on targeted therapeutics developed by the biopharmaceutical industry, and distribute our results and opinion via the Society’s website, presentations and publications. The Society also engages with government and international agencies on matters of importance to the antibody community.

Become an Event Sponsor or Exhibitor at Our 2018 Meeting

Highlight your products and services to 900+ antibody scientists and executives from North America, Asia and Europe.  To request a 2017 floor plan, or to see a list of available package options, please contact Aimee Croke at or +1-857-504-6697.

Hotel and Venue

Manchester Grand Hyatt San Diego

1 Market Place, San Diego, CA 92101

Phone: (888) 421 -1442